ArticleTheranostics2023

Discovery of a novel NAMPT inhibitor that selectively targets NAPRT-deficient EMT-subtype cancer cells and alleviates chemotherapy-induced peripheral neuropathy.

Minjee Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.